The document provides an overview of monobactams, a class of β-lactam antibiotics, highlighting their structure, synthesis, and antibacterial properties. Aztreonam, the key monobactam discussed, is exclusively effective against gram-negative bacteria and shows resistance to β-lactamases. The document also compares aztreonam with newer monobactams like tigemonam, emphasizing their clinical relevance and spectrum of activity.